Keyword: Genmab

News

Genmab Completes Acquisition of ProfoundBio

22.05.2024 -

Genmab has completed its $1.8 billion acquisition of ProfoundBio, a clinical-stage biotechnology company developing next-generation antibody-drug conjugates (ADCs) and...

News

Genmab to Acquire ProfoundBio for $1.8 Billion

04.04.2024 -

Danish drugmaker Genmab has agreed to buy privately-owned US biotechnology company ProfoundBio for $1.8 billion. ProfoundBio develops novel ADCs and ADC technologies for...

News

AbbVie Agrees Cancer Collaborations

17.06.2020 - US drugmaker AbbVie has signed two separate collaboration agreements, one with Denmark’s Genmab and the other with China’s Jacobio Pharmaceuticals, for developing and...

News

J&J Steps Up Partnership Drive with Four New Centres

18.09.2012 - Johnson & Johnson is stepping a drive to tap into emerging healthcare technology by establishing new innovation centres in four of the world's biotech hot spots - California...

News

Genmab CEO Worried By Takeover Risk

28.10.2010 - Danish-listed biotech Genmab is vulnerable to a takeover due to its current low share price, and the company needs more time to develop its full potential, its chief executive told...